These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1725608)

  • 1. [Clinical importance of human plasma proteins and their future development].
    Schwick HG
    Beitr Infusionsther; 1991; 28():115-23. PubMed ID: 1725608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status and trends in blood biologicals].
    Wang Z; Zhao X; Lv M; Zhang J
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):730-46. PubMed ID: 21845840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recombinant plasma proteins for therapeutic use--status and developmental trends].
    Storch H
    Beitr Infusionsther; 1993; 31():31-7. PubMed ID: 7693261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma protein therapies: current and future perspectives.
    Farrugia A; Robert P
    Best Pract Res Clin Haematol; 2006; 19(1):243-58. PubMed ID: 16377552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemistry and clinical significance of human plasma proteins].
    Haupt H
    Behring Inst Mitt; 1990 Oct; (86):1-66. PubMed ID: 2252458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotechnology: alternatives to human plasma-derived therapeutic proteins.
    Lynch TJ
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):669-88. PubMed ID: 11102283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The main characteristics of blood products in current use].
    Lambert T
    Rev Prat; 1989 Sep; 39(20):1745-9. PubMed ID: 2814257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemostasis management in multiple trauma patients--value of near-patient diagnostic methods].
    Jámbor C; Heindl B; Spannagl M; Rolfes C; Dinges GK; Frietsch T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):200-9; quiz 211. PubMed ID: 19266421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and plasma products in the treatment of massive haemorrhage.
    Erber WN; Perry DJ
    Best Pract Res Clin Haematol; 2006; 19(1):97-112. PubMed ID: 16377544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Norwegian Plasma Fractionation Project--a 12 year clinical and economic success story.
    Flesland O; Seghatchian J; Solheim BG
    Transfus Apher Sci; 2003 Feb; 28(1):93-100. PubMed ID: 12620274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.
    Kim HW; Greenburg AG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):537-50. PubMed ID: 17090427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of prions during plasma protein manufacture.
    Burdick MD; Pifat DY; Petteway SR; Cai K
    Transfus Med Rev; 2006 Jan; 20(1):57-62. PubMed ID: 16373188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic use of hemoderivatives].
    Yurrebaso Eguilior N; Mota Villaplana FM; Montoro Ronsano JB
    Sangre (Barc); 1997 Oct; 42(5):423-7. PubMed ID: 9424747
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma component therapy: new trends.
    Rudowski WJ; Scharf R
    Surg Annu; 1986; 18():311-26. PubMed ID: 3510468
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant plasma proteins.
    Burnouf T
    Vox Sang; 2011 Jan; 100(1):68-83. PubMed ID: 21175657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotechnology of plasma proteins. Fractionation and applications.
    Stoltz JF; Rivat C
    Beitr Infusionsther; 1989; 24():74-82. PubMed ID: 2481552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic engineering and coagulation factors.
    Fass DN; Toole JJ
    Clin Haematol; 1985 Jun; 14(2):547-70. PubMed ID: 3930118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma fractionation in the world: current status].
    Burnouf T
    Transfus Clin Biol; 2007 May; 14(1):41-50. PubMed ID: 17499539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG
    Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.